WallStSmart

Campbell’s Co (CPB)vsJBS N.V. (JBS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 738% more annual revenue ($84.15B vs $10.04B). CPB leads profitability with a 5.5% profit margin vs 2.5%. CPB trades at a lower P/E of 11.3x. CPB earns a higher WallStSmart Score of 57/100 (C).

CPB

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 5.5Value: 7.3Quality: 4.8
Piotroski: 5/9Altman Z: 1.54

JBS

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 2.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPBSignificantly Overvalued (-134.4%)

Margin of Safety

-134.4%

Fair Value

$12.51

Current Price

$20.81

$8.30 premium

UndervaluedFair: $12.51Overvalued
JBSSignificantly Overvalued (-132.0%)

Margin of Safety

-132.0%

Fair Value

$7.00

Current Price

$15.75

$8.75 premium

UndervaluedFair: $7.00Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPB3 strengths · Avg: 8.7/10
P/E RatioValuation
11.3x10/10

Attractively priced relative to earnings

PEG RatioValuation
0.558/10

Growing faster than its price suggests

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

JBS3 strengths · Avg: 8.3/10
Return on EquityProfitability
24.1%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
13.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

CPB4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Revenue GrowthGrowth
-4.5%2/10

Revenue declined 4.5%

EPS GrowthGrowth
-17.2%2/10

Earnings declined 17.2%

JBS3 concerns · Avg: 2.0/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

Debt/EquityHealth
2.561/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CPB

The strongest argument for CPB centers on P/E Ratio, PEG Ratio, Price/Book. PEG of 0.55 suggests the stock is reasonably priced for its growth.

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.4% demonstrates continued momentum.

Bear Case : CPB

The primary concerns for CPB are Altman Z-Score, Profit Margin, Revenue Growth.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, EPS Growth, Debt/Equity. Debt-to-equity of 2.56 is elevated, increasing financial risk. Thin 2.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

JBS is growing revenue faster at 13.4% — sustainability is the question.

JBS generates stronger free cash flow (543M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CPB scores higher overall (57/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Campbell’s Co

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Campbell Soup Company, doing business as Campbell's, is an American processed food and snack company.

Visit Website →

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

Want to dig deeper into these stocks?